Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
0.3429
-0.0076 (-2.17%)
At close: Jun 20, 2025, 4:00 PM
0.3499
+0.0070 (2.04%)
After-hours: Jun 20, 2025, 7:49 PM EDT

Applied Therapeutics Stock Forecast

APLT's stock price has decreased by -92.38% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 7 analysts that cover Applied Therapeutics stock have a consensus rating of "Buy" and an average price target of $6.1, which forecasts a 1678.94% increase in the stock price over the next year. The lowest target is $1.5 and the highest is $14.

Price Target: $6.1 (+1678.94%)
Analyst Consensus: Buy
Target Low Average Median High
Price $1.50 $6.10 $5.00 $14
Change +337.45% +1678.9% +1358.2% +3982.8%
* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Applied Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '25Feb '25Mar '25Apr '25May '25Jun '25
Strong Buy 111111
Buy 333333
Hold 333333
Sell 000000
Strong Sell 000000
Total 777777

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
RBC Capital
RBC Capital
Hold
Reiterates
$1.5
Hold Reiterates $1.5 +337.45% May 14, 2025
William Blair
William Blair
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Dec 23, 2024
RBC Capital
RBC Capital
Hold
Maintains
$4$1.5
Hold Maintains $4$1.5 +337.45% Dec 20, 2024
UBS
UBS
Hold
Downgrades
$13$2
Hold Downgrades $13$2 +483.26% Dec 2, 2024
Citigroup
Citigroup
Strong Buy
Maintains
$13$8
Strong Buy Maintains $13$8 +2,233.04% Nov 29, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
8.50M
from 455.00K
Increased by 1,768.13%
Revenue Next Year
33.39M
from 8.50M
Increased by 292.85%
EPS This Year
-0.59
from -0.76
EPS Next Year
-0.47
from -0.59
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
---9.99M455.00K8.50M33.39M73.45M
Revenue Growth
-----95.45%1,768.13%292.85%119.97%
EPS
-4.28-4.12-2.18-1.42-0.76-0.59-0.47-0.36
EPS Growth
--------
Forward PE
--------
No. Analysts
-----654
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 10.5M 57.0M 95.9M
Avg 8.5M 33.4M 73.5M
Low 4.9M 10.2M 51.6M

Revenue Growth

Revenue Growth 20252026202720282029
High
2,207.7%
570.8%
187.3%
Avg
1,768.1%
292.8%
120.0%
Low
976.9%
19.4%
54.5%

EPS Forecast

EPS 20252026202720282029
High -0.48 -0.27 -0.34
Avg -0.59 -0.47 -0.36
Low -0.63 -0.70 -0.38

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.